Proteasome Inhibitors Evoke Latent Tumor Suppression Programs in Pro-B MLL Leukemias Through MLL-AF4

Chromosomal translocations disrupting MLL generate MLL-fusion proteins that induce aggressive leukemias. Unexpectedly, MLL-fusion proteins are rarely observed at high levels, suggesting excessive MLL-fusions may be incompatible with a malignant phenotype. Here, we used clinical proteasome inhibitors...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Liu, Han, Westergard, Todd D., Cashen, Amanda, Piwnica-Worms, David R., Kunkle, Lori, Vij, Ravi, Pham, Can G., DiPersio, John, Cheng, Emily H., Hsieh, James J.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4097146/
https://ncbi.nlm.nih.gov/pubmed/24735925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2014.03.008
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items